TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/2/22 17:02 | 7/29/22 | TALS | Talaris Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Requadt Scott | KY | DO | CEO | P | 167 | 4.25 | 0 | 39 | 4 | 958 | D | ||||||||||||||
7/28/22 19:52 | 7/26/22 | TALS | Talaris Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Requadt Scott | KY | DO | CEO | P.m | 37 | 4.24 | 0 | 9 | 1 | 919 | D | ||||||||||||||
7/26/22 19:38 | 7/22/22 | TALS | Talaris Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Requadt Scott | KY | DO | CEO | P | 35 | 3.75 | 0 | 9 | 1 | 910 | D | ||||||||||||||
6/18/18 10:51 | 6/14/18 | VBIV | Vbi Vaccines Inc/bc | A1 | Health | Drug | Pharmaceutical Preparations | Requadt Scott | MA | D | M.d | 0 | 0.00 | 0 | 13 | 50 | 38 | D | |||||||||||||||
6/16/17 17:59 | 6/14/17 | VBIV | Vbi Vaccines Inc/bc | A1 | Health | Drug | Pharmaceutical Preparations | Requadt Scott | MA | D | M.d | 0 | 0.00 | 0 | 13 | 100 | 25 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |